Co-payment
|
+
|
Stuart and Zacker [123] (US, OS, CD, R)
|
Co-payment
|
0
|
Lurk et al. [27] (US, NS, CD, R)
|
Multi-tier formulary (vs. 1- or 2-tiers)
|
+
|
Huskamp et al. [124] (US, NS, CD, R); Huskamp et al. [125] (US, NS, CD, R); Kamal-Bahl and Briesacher [91] (US, OS, CD, R)
|
Reference pricing
|
+
|
Grootendorst et al. [101] (CA, NS, TD, R)
|
Insurance coverage
| | |
Supplementary (vs. none)
|
-
|
Alan et al. [69] (CA, OS, CD, R); Alan et al. [68] (CA, OS, CD, R); Alan et al. [126] (CA, OS, CD, R); Blustein [127] (US, OS, CD, R); Federman et al. [114] (US, OS, CD, R)
|
Reimbursement limit
|
+
|
Tseng et al. [128] (US, OS, CD, NR)
|